Charter Oak Capital Management’s Amgen AMGN Stock Holding History

Charter Oak Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$331K	Sell	942 -3	-0.3%	-$1.07K	0.03%	153
2025 Q4	$309K	Buy	945 +15	+2%	+$4.76K	0.02%	165
2025 Q3	$262K	Buy	930 +102	+12%	+$29.6K	0.02%	179
2025 Q2	$231K	Buy	828 +113	+16%	+$32K	0.02%	186
2025 Q1	$223K	Buy	+715	New	+$211K	0.02%	183
2024 Q4	–	Sell	-794	Closed	-$256K	–	182
2024 Q3	$256K	Buy	+794	New	+$260K	0.02%	166
2022 Q3	–	Sell	-784	Closed	-$191K	–	190
2022 Q2	$191K	Sell	784 -26	-3%	-$6.37K	0.03%	174
2022 Q1	$196K	Sell	810 -105	-11%	-$24.1K	0.02%	186
2021 Q4	$206K	Hold	915	–	–	0.02%	182
2021 Q3	$195K	Buy	915 +12	+1%	+$2.76K	0.02%	175
2021 Q2	$220K	Sell	903 -12	-1%	-$2.95K	0.03%	161
2021 Q1	$228K	Buy	915 +105	+13%	+$25.1K	0.03%	162
2020 Q4	$186K	Buy	+810	New	+$187K	0.03%	167

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charter Oak Capital Management's AMGN Position: Q1 2026 in Review

Charter Oak Capital Management reduced its Amgen (AMGN) stake by 0.32% in Q1 2026, selling an estimated $1.07K and leaving 942 shares worth $331K. The position accounts for 0.03% of the portfolio, ranked #153.

Charter Oak Capital Management first reported a position in AMGN in Q4 2020 and has held it in 13 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Charter Oak Capital Management held 942 shares of Amgen worth $331K as of Q1 2026.
Charter Oak Capital Management sold 3 Amgen shares in Q1 2026, an estimated $1.07K.
Amgen made up 0.03% of Charter Oak Capital Management's portfolio in Q1 2026, its #153 holding.
Charter Oak Capital Management first reported a position in Amgen in Q4 2020 and has held it in 13 quarters since.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.